EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Harmine-mediated Reduction of Bone Cancer Pain in Rats Correlates With Suppressed DYRK1A/NF-κB Signaling Axis

Shuyao Zhang, Shang Zheng, Jia Jin, Yuhua Li, Liping Chen, Junjie Lin, Ming Yao, Longsheng Xu

Journal of Integrative Neuroscience · 23.06.2025 · 24 (6)

DOI: 10.31083/jin38100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Integrative Neuroscience, online erschienen am 23.06.2025. Verfasst von Shuyao Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences and Medicine, Zhejiang Sci-Tech University, 310018 Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Harmine, Bone Neoplasms, Cancer Pain, Signal Transduction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China, People's Livelihood Science and Technology Innovation Research Project of Jiaxing City.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bone cancer pain (BCP) is a prevalent chronic pain condition and a common clinical symptom in patients with advanced cancer. It significantly affects the mobility and quality of life of patients; however, current treatments offer limited efficacy. Harmine, a beta-carboline alkaloid extracted from Peganum harmala, exhibits anti-inflammatory, anxiolytic, analgesic, and neuroprotective properties. However, its antinociceptive properties and mechanisms in BCP models remain unclear. This study aimed to systematically investigate the analgesic effects of Harmine in rats with BCP and explore its underlying molecular mechanisms.

Methods

Using databases such as SwissTargetPrediction and Polypharmacology Browser, molecular docking analysis, behavioral tests, and biochemical analysis, we comprehensively evaluated the effects of Harmine in the BCP model.

Results

The results demonstrated that Harmine significantly alleviated BCP induced by Luciferin-Malignant Atypical Discrete Breast 106 cells (LUC-MADB106) in a dose-dependent manner. Intrathecal administration of Harmine significantly inhibited the upregulation of dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) expression and the activation of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway in the spinal cord dorsal horn (SCDH) of rats with bone cancer.

Conclusions

These findings suggest that Harmine has significant therapeutic potential for alleviating BCP hyperalgesia, providing a foundation for the future development of new drugs targeting BCP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HarmineBone NeoplasmsCancer PainSignal TransductionProtein-Tyrosine KinasesNF-kappa BProtein Serine-Threonine KinasesAnalgesicsAnimalsRatsDyrk KinasesDisease Models, AnimalRats, Sprague-DawleyFemaleSpinal Cord Dorsal Horn

Stichwörter der Autor:innen

DYRK1A/NF-κB signaling pathwayHarminebone cancer painspinal cord dorsal horn

Substanzen

HarmineProtein-Tyrosine KinasesNF-kappa BProtein Serine-Threonine KinasesDyrk KinasesAnalgesics

Autor:innen und Institutionen

  • College of Life Sciences and Medicine, Zhejiang Sci-Tech University, 310018 Hangzhou, Zhejiang, China.
  • Department of Anesthesiology and Pain Research Center, Jiaxing University Affiliated Hospital, The First Hospital of Jiaxing, 314001 Jiaxing, Zhejiang, China.

Förderung

  • Natural Science Foundation of Zhejiang Province
  • National Natural Science Foundation of China
  • People's Livelihood Science and Technology Innovation Research Project of Jiaxing City
  • Clinical Key Specialties of Zhejiang Province -Anesthesiology
  • National Clinical Key Specialties-Oncology
  • People’s Livelihood Science and Technology Innovation Research Project of Jiaxing City

Zitieren

APA

Zhang, S., Zheng, S., Jin, J., Li, Y., Chen, L., Lin, J., Yao, M., & Xu, L. (2025). Harmine-mediated Reduction of Bone Cancer Pain in Rats Correlates With Suppressed DYRK1A/NF-κB Signaling Axis. Journal of Integrative Neuroscience, 24(6). https://doi.org/10.31083/jin38100

Vancouver

Zhang S, Zheng S, Jin J, Li Y, Chen L, Lin J, et al. Harmine-mediated Reduction of Bone Cancer Pain in Rats Correlates With Suppressed DYRK1A/NF-κB Signaling Axis. Journal of Integrative Neuroscience. 2025;24(6). doi:10.31083/jin38100

BibTeX
@article{Zhang2025,
  author = {Zhang, Shuyao and Zheng, Shang and Jin, Jia and Li, Yuhua and Chen, Liping and Lin, Junjie and Yao, Ming and Xu, Longsheng},
  title = {Harmine-mediated Reduction of Bone Cancer Pain in Rats Correlates With Suppressed DYRK1A/NF-κB Signaling Axis},
  journal = {Journal of Integrative Neuroscience},
  year = {2025},
  volume = {24},
  number = {6},
  doi = {10.31083/jin38100}
}
Kostenlos starten →